Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord Injury

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of ALMB-0166 in patients with acute spinal cord injury.
Epistemonikos ID: 507150278cf74bf18a0d61d022a62876e055242e
First added on: May 13, 2024